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Abstract
Murine models of human genetic disorders provide a valuable tool for investigating the scope for application of induced
pluripotent stem cells (iPSC). Here we present a proof-of-concept study to demonstrate generation of iPSC from a mouse
model of X-linked chronic granulomatous disease (X-CGD), and their successful differentiation into haematopoietic
progenitors of the myeloid lineage. We further demonstrate that additive gene transfer using lentiviral vectors encoding
gp91phox is capable of restoring NADPH-oxidase activity in mature neutrophils derived from X-CGD iPSC. In the longer term,
correction of iPSC from human patients with CGD has therapeutic potential not only through generation of transplantable
haematopoietic stem cells, but also through production of large numbers of autologous functional neutrophils.
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Introduction
The successful application of induced pluripotent stem cell
(iPSC) technology in murine models of human diseases, and in
generating disease-free autologous cells from patient samples offers
considerable potential for development of personalized cell based
therapies of monogenic disorders [1–9]. In this study, we have
studied a mouse model of X-linked chronic granulomatous
disorder (X-CGD)[10]. CGD is a group of inherited immunode-
ficiency disorders resulting from mutations in any one of five
subunits of the NADPH-oxidase found in neutrophils and other
phagocytic leukocytes. Patients with CGD typically present early
in life with recurrent and life-threatening infections due to
impaired killing of ingested microbes. Two-thirds of patients with
CGD have mutations in the X-linked CYBB gene on chromosome
Xp21.1 encoding membrane bound gp91phox (where phox stands for
phagocyte oxidase). X-CGD in human patients can be cured by
haematopoietic stem cell transplantation from HLA genotypically-
matched donors with high rate of success. Gene therapy using
gammaretroviral vectors has also proved to be useful for short
term treatment of life-threatening infection, although complicated
by insertional mutagenesis. Treatment of those patients without
HLA-matched donors remains problematic. In addition to
haematopoietic stem cell (HSC) based therapy, refractory
infections in CGD patients can be successfully treated using
repeated infusions of functional allogeneic neutrophils, although
this strategy often results in exaggerated inflammation and allo-
immunisation[11–14]. In this study, we provide a proof-of-
principle that iPSC technology can provide a valuable platform
for investigating gene therapeutic approaches in CGD.
Results and Discussion
Induced pluripotent stem cells (iPSCs) generated from adult
fibroblasts of X-CGD mice were adapted to feeder-free condition
for five passages and subsequently characterized for stem cell
morphology (round shape, large nucleus, and scant cytoplasm),
alkaline phosphatase activity, and expression of pluripotency
markers Sox2, Oct4, Klf4, Nanog, SSEA-1, and c-Myc (Fig. 1A).
Based on these results, a single clone was selected for future
experiments henceforth designated as cgd-iPSC. As control, an
iPSC clone from wild-type mice of identical background was also
obtained which will be referred to as wt-iPSC. The ability to
generate teratoma in immunodeficient mice constitutes an
important test of pluripotency. Sub-cutaneous injection of cgd-
iPSC into immunodeficient mice generated tumour between the
4th and 5th week and subsequent histological analysis of tumour
sections revealed the presence of ectodermal (neural tube),
mesodermal (cartilage) and endodermal (gut epithelium) structures
as shown in figure 1B. Immunostaining revealed the presence of
definitive markers for all three germinal layers in these sections
(Figure 1C) thereby confirming the tumour growth as a teratoma.
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Complete silencing of retroviral transgenes marks the attainment
of a fully reprogrammed pluripotent state. This is immensely
critical for the employment of iPSC in multi-lineage differentiation
protocols[15,16]. As shown in figure 1D, we could not detect any
expression of the exogenous reprogramming factors from the
retroviral vectors in cgd-IPSC (passage five) when compared to
transduced fibroblasts (day three). Expressions of endogenous
reprogramming factor transcripts were consistently detected in
cgd-IPSC when cultured and propagated in embryonic stem cell
media.
Our next goal was to differentiate the cgd-iPSC line to cells of
myeloid lineage. Myeloid differentiation is a complex process
involving coordinated binding of haematopoietic cytokines
(notably granulocyte-colony stimulating factor and IL-6) to their
cognate receptors in a stage and lineage specific manner resulting
in the derivation of mature granulocytes or monocytes/macro-
phages. The scheme for differentiation is outlined in figure 2A and
is adapted from previously published protocols for in-vitro
haematopoietic differentiation of mouse embryonic stem cells
and iPSC with minor modifications[17]. RNA expression profiling
of six day old embryoid bodies (EBs) showed down regulation of
expression of the pluripotency markers (Nanog and Oct4), with
concomitant upregulation in expression of differentiation markers
including Nestin (ectoderm), a-fetoprotein (AFP) (endoderm), and
mesodermal markers such as Flt-1 (FMS like tyrosine kinase I), and
Brachyury (Fig 2B, left panel) confirming the ability of this clone to
undergo directed differentiation. In-situ immunostaining further
confirmed the presence of cellular derivatives from all three
germinal layers (Fig 2B, middle panel).
It has been previously shown that reprogrammed murine
fibroblasts can be induced to differentiate into cells of the
mesodermal lineages when cultured on collagen type IV
(ColIV)[18]. We cultured day six EBs on ColIV coated flasks for
an additional 4 days. Gene expression profiling at this stage
revealed the presence of several haematopoietic markers including
c-kit, Sca1, homeobox protein B4 (HoxB4), runt-related transcrip-
tion factor 1 (RunX1), transcription factor PU.1, LIM domain
only 2 (Lmo2) and Eto2 (Figure 2B, right panel). Fluorescence-
activated cell sorting (FACS) also revealed the presence of Flk-1
positive progenitor cells. Flk-1 is a candidate marker for mesoderm
and hemangioblast cells which are known to have the ability to
differentiate into cells of haematopoietic as well as endothelial
lineages [19,20]. The conversion rate (EB to Flk-1 progenitors) was
similar in the diseased versus normal iPS derived populations as
shown in figure 2C. Sorted Flk-1-positive cells were further co-
cultured with the OP9 stromal cell line in defined medium
containing haematopoietic cytokines. Co-culture with OP9 has
been shown to confer myelo-erythroid potential to mouse
haematopoietic stem cells [21,22]. Between days three and five
of cgd-IPSC and OP9 co-culture, we were able to detect the
presence of a lineage negative, Sca-1 positive, c-kit positive (LSK)
population of nascent haematopoietic stem cells (7.38%) as shown
in figure 2D. This compared closely to the numbers (9.9%)
obtained from wt-IPSc (data not shown).
LSK cells were assayed for their clonogenic haematopoietic
potential by culturing in semi-solid medium containing suitable
cytokines promoting myeloid differentiation. It has been shown
previously that lineage negative, Sca-1 positive bone marrow cells
consist of a virtually pure population of multilineage haematopoi-
etic stem cells[23]. Between one to two weeks later, colonies were
scored based on their morphology (CFU-GM, CFU-G, and CFU-
M). Both wt-iPSC and cgd-iPSC showed similar distribution in the
formation of CFUs (Figure 3A). Cytospin preparations from the
cgd-iPSC-derived colonies showed the presence of mature
neutrophils, macrophages and monocytes (Figure 3B). This was
confirmed by flow cytometric analysis which showed the presence
of double positive Gr-1 (myeloid differentiation antigen) and
CD11b (macrophage and granulocyte marker) cell populations
(71%) which compared closely to those derived from wt-iPSCs
(85%) (Figure 3C). This demonstrates as expected that the
inherent genetic defect does not interfere with the potential of
cgd-iPSC to generate terminally differentiated granulocytes/
monocytes.
For gene correction, EBs derived from cgd-iPSC (six days) were
transduced with a self-inactivating (SIN) lentiviral vector encoding
a codon optimized gp91phox transgene expressed from an internal
spleen focus forming virus (SFFV) derived promoter (Len-
tiSFFVgp91) at different multiplicities of infection (m.o.i). CFU
derived from transduced EBs were analysed for functional activity
of the NADPH-oxidase by Nitroblue Tetrazolium (NBT) assay.
CFUs derived from lentivirus transduced EBs showed positive
staining in the NBT assay (Figure 4A, ii) compared to
untransduced control cells (Figure 4A, i). We also observed a
positive correlation between the percentage of NBT positive CFUs
and increasing m.o.i (Figure 4A). This is most likely due to better
transduction efficiency of EBs. Surprisingly, when compared
against percentage of NBT positive CFUs (70.2%63.8) derived
from wild-type iPSC (Figure 4B), we observed three-fold lower
efficiency of correction when fibroblasts (18.3%63.4), rather than
EBs (57.5%69.1) were transduced with the lentivector encoding
gp91phox. In this case we were able to detect the presence of
integrated provirus in the majority of NBT-negative CFUs derived
from fibroblast-transduced samples as shown in figure 4C (lane
NBT-, LV). Analysis of the CpG islands in the SFFV promoter/
enhancer region revealed extensive methylation (indicated by filled
boxes in figure 4D, left panel) indicating that epigenetic silencing
during reprogramming and subsequent differentiation is likely to
have occurred[24,25]. In contrast, presence of integrated vector
could not be detected in any of NBT-negative clones derived from
transduced EBs, indicating that they were not actually transduced
(data not shown). Furthermore, the levels of vector methylation in
the NBT positive clones derived from the same EB cultures was
much lower (Figure 4D, right panel). We also used a newly
described SIN lentivector regulating the expression of gp91phox
Figure 1. Reprogramming of X-CGD mouse fibroblasts to induced pluripotent stem cells. (A) Images of iPSC showing ES cell like
morphology (high nucleus to cytoplasm ratio), high levels of alkaline phosphatase (AP) activity, and expression of pluripotency markers Sox2, Oct4,
Klf4, Nanog, SSEA-1, and c-Myc. Bright-field images were acquired with a standard Olympus microscope (20X objective). Fluorescent images were
acquired with a Zeiss LSM 710 confocal microscope (25X objective). (B) Haematoxylin & Eosin staining of teratoma sections showing derivatives from
three germinal layers (Ecto, ectoderm; Endo, endoderm; Meso, mesoderm). Structures shown include neural tube (ectodermal), striated muscles and
cartilaginous structures (mesodermal), and gut-like epithelium (endodermal). (C) Immunofluorescent confocal images of teratoma sections showing
antibody staining targeting tissue derivatives present in three germinal layers.Tuj1: neuronal class III b-tubulin; /-FP: alpha-fetoprotein; /-act: alpha-
actinin; DAPI: 49-6-Diamidino-2-phenylindole.(D) Semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) analyses showing
silencing of exogenously introduced transgenes as shown by their presence in fibroblasts (three days post transduction, D3), and absence in cgd-IPSC
clone (passage five). Specific primers were designed to target regions of retroviral transgenes and endogenous sequences of reprogramming factors.
GAPDH, glyceraldehdye 3-phosphate dehydrogenase.
doi:10.1371/journal.pone.0017565.g001
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from a chimeric promoter consisting of the myeloid-specific
minimal c-fes promoter fused to cathepsin-G regulatory sequenc-
es[26]. EBs transduced with this vector showed similar levels of
correction of disease phenotype as revealed by NBT assay
(Figures 5A and 4A). We also estimated the ability of the chimeric
vector to restore respiratory burst activity using a more
quantitative assay which measures change in fluorescence of
dihydrorhodamine 123 (DHR)-loaded CD11b/Gr1 + neutrophils
after PMA stimulation. As shown in figure 5B, untransduced cgd-
iPSC-derived granulocytes showed no significant difference
between PMA stimulated and unstimulated samples (top panel);
wt-iPSC-derived cells showed a significant shift in fluorescence
upon stimulation indicating reduction of DHR123 to rhodamine
by reactive oxygen species(middle panel); DHR-loaded neutrophils
derived from cgd-iPSC EBs transduced by the chimeric vector
showed a shift in fluorescence peak upon stimulation that was
comparable to that of wild type cells (45.28% of total number of
cells for wt-iPSC compared to 44.19% of vector transduced cgd-
iPSC).
In this study we have demonstrated successful generation of
iPSCs from X-CGD mice and their induced differentiation into
haematopoietic myeloid progenitors and functional neutrophils. We
observed no significant difference between iPSCs generated from
wild-type mice and those generated from X-CGD mice regarding
their ability to differentiate. We have also demonstrated in-vitro
restoration of NADPH-oxidase activity in derived X-CGD
granulocytes by transduction of the iPSCs (preferentially at EB
stage) with lentivectors expressing the gp91phox, and therefore have
provided a proof-of-principle that iPSC technology can be
combined with gene therapeutic approaches for modelling a rare
primary immunodeficiency such as CGD. Vector design is an
important consideration for effective genetic correction of cells prior
to reprogramming as epigenetic modifications during this process
may lead to irreversible silencing. Utilisation of iPSC for screening
alternative vector configurations may therefore prove to be
particularly useful. Further investigation is needed to determine if
haematopoietic stem cells (HSCs) generated from the gene
corrected iPS cells can be employed for long-term multi-lineage
reconstitution of murine models and functional correction of the
disease phenotype (i.e. susceptibility to invading microorganisms).
Derivation of HSCs from human embryonic stem (hES) cell lines
and iPSC remains a significant hurdle to translation of this
technology, but has obvious clinical application for transplantation.
Several groups have recently reported the successful derivation of
mature and functional neutrophils from hES cell lines[27,28], as
well as from human iPSCs[29]. Production of large numbers of
gene-corrected mature myeloid effector cells from patients with
CGD may therefore also have significant therapeutic potential.
Materials and Methods
Ethics statement
All animals were handled in strict accordance with good animal
practice as defined by UK Home Office Animal Welfare
Legislation, and all animal work was approved by the Institutional
Research Ethics Committee (Institute of Child Health, University
College London, UK) and performed under project license
number 70/7024.
Vectors
Generation and titration of retroviral vectors used for repro-
gramming adult fibroblasts isolated fromX-CGDmice, and the self-
inactivating (SIN) lentiviral vectors used for the purpose of
correcting the X-CGD genetic defect have been previously
described [5,26]. Briefly, for retroviral vector generation, 293T
cells were transiently transfected with packaging plasmid expressing
Murine Leukemia virus-gag/pol, Vesicular stomatitis virus derived
G protein (VSV-G) expressing plasmid pMD.G2, and pMXS-based
reprogramming vectors [5] using standard polyethyelnimine (PEI)
protocol. Viral supernatant was harvested forty-eight hours and
seventy-two hours post-transfection and concentrated by ultra-
centrifugation, and stored in aliquots in -80uC. For VSV-G
pseudotyped lentiviral vector generation an identical protocol was
followed employing a HIV-1 gag/pol packaging plasmid
pCMVDR8.74, pMD.G2, and transducing vector pCCLChim-
c.o.gp91phox or pCCLSFFVcogp91phox [26] (referred in the text as
LentiChimgp91phox and LentiSFFVgp91phox respectively).
Animals
X-CGD mice B6.129S6-Cybbtm1Din/J deficient on gp91phox [9]
and wild-type Blck6Ly5.2 mice were obtained from Jackson
Laboratories (USA).
Cell culture and iPSC generation
Adult mouse fibroblasts isolated from X-CGD mice using
standard protocol were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) [Invitrogen, CA] supplemented with 10% fetal
calf serum (FCS) and 1% penicillin-streptomycin for two to three
passages under standard conditions and then frozen into aliquots.
The day before transduction, 56104 fibroblasts were seeded on
each well of a six-well plate. Next day, the cells were infected with
a cocktail of retroviral reprogramming vectors together with
protamine sulphate. After three days, transduced cells were split
into gelatine-coated six-well plates and maintained in ESGRO
Complete Plus Clonal medium [Millipore] with regular medium
changes until colonies appear and are ready for clonal isolation
and expansion. The iPSC were cultured feeder-free on gelatine-
coated flasks in ESGRO Complete Plus Clonal medium at 37uC,
5% CO2. Cells were passaged using Accutase [Millipore].
Teratoma generation
16106 iPS cells in matrigel (per site per injection) were injected
subcutaneously into immunodeficient mice [common c-chain-/-,
RAG2-/-, C5-/-]. Mice were sacrificed within 4-6 weeks after
injection and teratoma was dissected and processed for haema-
toxylin/eosin staining and immunostaining with suitable antibod-
ies. Following primary antibodies along with suitable secondary
Figure 2. In-vitro differentiation of iPS cells towards mesodermal and haematopoietic lineages. (A) Schematic representation of protocol
for haematopoietic differentiation of X-CGD mouse derived iPS cells. EB, embryoid bodies; ColIV, collagen type IV coated plate; Flk-1+ cells, FMS-like
tyrosine kinase I positive cells; OP9, M-CSF deficient OP9 stromal cell line; LSK, Lineage negative, Sca-1 positive, c-kit positive cells. (B) Characterization
of day six EB cultured under low-attachment conditions. Semi-quantitative RT-PCR analyses showing comparative expression of pluripotency and
differentiation markers in wild-type (wt-IPSC) and diseased iPS cells (cgd-IPSC). Left panel shows expression levels of various markers in day six EBs,
while those in the right panel shows comparative levels of expression in cells after culturing in collagen IV coated flasks in haematopoietic
differentiation medium. Middle panel shows in-situ immunophenotypic staining of six-day EBs with antibodies targeting characteristic antigens
expressed in the three germinal layers. (C) FACS analysis showing generation of Flk-1 positive cells from EBs upon collagen IV culture.(D) FACS plot
showing derivation of lineage negative, Sca-1 positive and c-kit positive (LSK) population post OP9 co-culture of Flk-1 positive cells.
doi:10.1371/journal.pone.0017565.g002
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Figure 3. Myeloid differentiation of iPS cell derived LSK cells. Colony Forming Unit (CFU) assay was performed to test the ability of LSK cells to
undergo terminal differentiation in semi-solid methylcellulose media containing suitable cytokine cocktail. (A) Graph showing the relative distribution
of CFU-GM (granulocyte/macrophage), CFU-G (granulocyte), and CFU-M (macrophage) colonies scored on the basis of their morphology from three
independent cultures. Error bars denote standard error of mean (SEM). (B) Representative cytospin preparation of Diff-Quik stained cells isolated from
characteristic colonies showing presence of granulocytes and macrophages including and not restricted to mature and functional neutrophils. (C) FACS
plot showing presence of double positive Gr-1 (granulocyte differentiation marker) and CD11b (myeloid and NK cells marker) cells isolated from
colonies growing in methycellulose differentiation medium.
doi:10.1371/journal.pone.0017565.g003
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Figure 4. Correction of X-CGD phenotype in-vitro. (A) Phase contrast images showing results of Nitroblue tetrazolium (NBT) assay. Left panel
showing untransduced NBT negative (i) and LentiSFFVgp91 transduced NBT positive (ii) colony. Graph showing positive correlation between the
multiplicity of infection (m.o.i) and generation of NBT positive colonies. (B) Comparative analysis of the efficiency of disease phenotype correction by
lentiviral transduction of pre- and post-reprogramming targets (fibroblasts vs EBs respectively), as assayed by percentage of NBT positive colonies.
Functional Neutrophils from X-CGD Mouse Model
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Restoration of NADPH oxidase activity was compared to number of NBT positive colonies obtained from wild-type iPSC derived myeloid progenitors.
Error bars denote standard error of mean (SEM). (C) Agarose gel electrophoresis image showing PCR amplification of SFFV promoter sequence in
genomic DNA of NBT negative CFUs confirming the presence of integrated vector. UT, untransduced; LV, Lentivector transduced. (D) Bisulphite
genomic sequencing analysis showing higher degree of methylation in lentiviral promoter (SFFV) when vector transduction was performed at the
fibroblast stage compared to EB stage. Filled boxes indicate methylated CpG dinucleotide.
doi:10.1371/journal.pone.0017565.g004
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conjugated antibodies were used in this study: anti-tubulin beta III
isoform (Tuj1) (ectodermal derivatives), anti-alpha-actinin (meso-
dermal derivatives), anti-alpha fetoprotein (endodermal deriva-
tives) (all from Millipore). As control for non-specific staining,
fluorophore-conjugated secondary antibodies were employed in
absence of primary antibodies. Teratoma images were processed
with ImageJ software.
In vitro differentiation
For Embryoid Body (EB) formation, iPSC were dissociated
using enzyme free cell dissociation buffer, resuspended in LIF free
medium and cultured at low attachment condition. For the
collagen IV cultures, iPSC derived EBs were triturated and
transferred to collagen IV-coated flasks [BD Biosciences]. For OP9
co-culture, Flk1-positive iPSC derived from collagen IV cultures
were enriched by fluorescence activated cell sorting (FACS) and
plated on OP9 stromal cells in 24 well plates at a concentration of
2 6 104 cells per well in 1 ml of a–minimum essential medium
[Invitrogen] supplemented with 20% FBS, 1% penicillin/strepto-
mycin, interleukin (IL)-3 (5 ng/ml), and granulocyte colony-
stimulating factor (GCSF; 10 ng/ml) for up to 7 days. Half of
the medium with cytokines was replaced every 2 days. OP9 cells
were obtained from American Type Cell culture (ATCC).
FACS analysis
Cells were pelleted by centrifugation, washed in PBS, and
stained with fluorescein isothiocyanate (FITC)-, phycoerythrin
(PE)-, or allophycocyanin (APC)-conjugated monoclonal rat anti-
mouse antibodies against Flk1, Sca1, c-Kit, Gr-1, and CD11b.
Nonspecific fluorochrome and isotype matched Ig’s served as
controls. Dead cells were excluded from analysis and all analysis
was performed using a BD LSRII flow cytometer. FACS data were
analyzed using FlowJo software.
Colony forming unit (CFU) assay
To determine the myeloid potential, iPSC derived Flk-1+,
lineage negative c-kit+, Sca-1+ cells were plated in methylcellulose
medium containing cytokines for myeloid differentiation [Meth-
ocult GF M3534; StemCell Technologies]. Colonies were scored
between 1-2 weeks.
NBT assay
Methylcellulose plate containing the CFUs was overlaid with
one-fifth volume of NBT-saturated RPMI-1640 medium (Invitro-
gen) containing 100 ng/ml PMA (Sigma) and 5% human serum
albumin (Baxter Healthcare, Deerfield, IL, USA) and incubated at
37uC. After 30 minutes of incubation, the dishes were examined
on an inverted microscope, and the colonies with blue formazan
precipitates were scored as NBT-positive.
DHR assay
CFU colonies were extracted from methylcellulose cultures and
washed rigorously to get rid of any methylcelluose. The cells were
incubated with 30 mM DHR at 37uC for 5 min and stimulated
with 5 mg/ml PMA at 37uC for 30 min.
Bisulphite sequencing
Genomic DNA was isolated from cells using the DNeasy kit
(Qiagen) and sodium bisulfite treatment of genomic DNA was
performed using the EpiTect bisulfite kit (Qiagen). PCR primers
were designed based on converted sequences. Primers were chosen
to cover partial length of the SFFV covering the enhancer region
(containing 11 CpG sites). PCR conditions were as follows: first
round, annealing temperature 58uC, 33 cycles; second round,
annealing temperature 56uC, 32 cycles. The PCR primer
sequences used were as follows: (i) SFFV promoter: Forward,
59GGG GGA ATG AAA GAT TTT ATT TG 39; Reverse, 59
TCT AAA AAC CAT CTA CTC TTA ACC T 39. PCR products
were cloned into TOPO-TA vector (Invitrogen) and sequenced.
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